ARCA biopharma, Inc. (ABIO) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
|
Results of Operations and Financial Condition. |
On November 14, 2016, ARCA biopharma, Inc. (ARCA) issued a press
release reporting financial results for the quarter ended
September 30, 2016.
The press release is attached hereto as Exhibit 99.1, which is
furnished under Item 2.02 of this report and shall not be deemed
to be filed for purposes of Section 18 of the Securities Exchange
Act of 1934 (the Exchange Act) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or
the Exchange Act, regardless of any general incorporation
language in such filing.
Section 9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit Number |
Description |
|
99.1 |
Press Release titled ARCA biopharma Announces Third |
About ARCA biopharma, Inc. (ABIO)